Experts in safe thawing and advance transport solutions for your cryopreserved biologics
Astero is now offering the ThawSTAR Automated Cell Thawing System product suite and BioT Temperature Stability Systems. CryoShell, a cryobag containment systems with advanced technical features to ensure your cell therapy is protected and monitored throughout the chain-of-custody is coming soon.
Astero Bio Corporation is a newly emerged, fast-growing corporation that specializes in novel tools and technologies for life science research, pharmaceutical manufacturing and clinical applications.
With a focus on cryopreservation and cold chain, Astero’s innovative product portfolio and product development pipeline provides expert solutions for cellular and immunotherapy, cell culture, biobanking and biologics. The company is committed to providing those that strive to improve patient health and wellness, the innovative tools and technologies to advance their success.
Samuel Kent, MBA, Chief Executive Officer
With over twenty years of experience in sales, business development and marketing leadership, Samuel Kent has successfully driven commercial success for a diverse portfolio of laboratory and clinical products and services. Prior to co-founding Astero Bio Corporation in 2018, he served in multiple executive, corporate and senior leadership roles at MedCision, BioCision, Thermo Fisher Scientific and Parker Hannifin. Mr. Kent graduated with his MBA from Colorado State University and his B.Sc from Northern Michigan University.
Brian Schryver, President and Chief Technology Officer
Brian Schryver’s life science tool and instrument developer career spans over 35 years. As a molecular biological research and development Scientist at Syntex, Mr. Schryver created innovative instruments to facilitate his research. His passion for invention carried forward during his work in preclinical development and biomarker research at SUGEN, and assay development at Corgentech. As co-founder of BioCision, in 2007, Mr. Schryver committed his full attention to developing innovative cold-chain instruments, and subsequently pioneered novel thawing technologies at MedCision. Mr Schryver has been awarded numerous patents and authored over 20 peer reviewed publications.
Tim Bush, Chief Financial Officer
Tim Bush is a seasoned Finance and Operations Executive with more than 30 years of experience providing structure and guidance to organizations to perform with operational efficiency. With over two decades working in the highly competitive disc drive industry, in the low margin contract manufacturing space, and with high technology companies, Mr. Bush took his leadership skills and operational savvy to startups in multiple industries. Mr. Bush holds a BS in Business Administration from Fresno State University and an MBA for Notre Dame de Namur University. He also is an Alumni of Stanford University Executive Education Program.
Astero Bio specializes in the development and commercialization of next-generation tools to aid in multiple stages of the lifecycles of biologics. Astero Bio’s ThawSTAR® Automated Cell Thawing Systems are designed to replace uncontrolled and highly variable manual methods, de-risking the therapeutic cell thawing process and optimizing cell efficacy. An industry first, ThawSTAR systems optimize cell thawing using a customizable algorithm for each unique cell therapy product and protocol. These systems, combined with Astero Bio’s ultra-low temperature cold storage and transport solutions, advance the physical management of biologics by providing safe, controlled and scalable processing of temperature-sensitive samples and products.